Canada’s Drug Agency reverses course, now recommends public drug plans cover Alzheimer’s drug

Agency says antibody medication lecanemab, which can slow cognitive decline, should be publicly reimbursed with conditions ...
Frontiers

Middle meningeal artery embolization in chronic subdural hematoma: bridging surgical innovations and molecular mechanisms

Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions in the elderly. Despite advances in burr-hole craniotomy, up to one-third of patients experience clinically ...